The "Sovereign Health" Pivot (Saudi & UAE)
2026 marks the peak of "Sovereign Health" initiatives, where GCC nations have moved to secure local supply chains for critical wellness products. Saudi Arabia and the UAE are no longer content with importing generic pharmaceuticals and supplements.
The Saudi Food and Drug Authority (SFDA) has streamlined its registration process, resulting in a surge of locally manufactured, halal-certified nutraceuticals. This shift is part of a broader "health security" strategy, ensuring that the region is resilient against global supply chain disruptions while fostering a domestic biotech sector that specializes in "bio-design" and preventive care
1 vue